



Live Webinar
Ask the Experts: The Intersection of GLP-1s, Body Size, and Eating Disorders
|
Ask the Experts: The Intersection of GLP-1s, Body Size, and Eating Disorders
1.5 CE Hours
Introductory
References
References
- Chen, X., Zhao, P., Wang, W., Guo, L., & Pan, Q. (2024). The Antidepressant Effects of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 32(1), 117–127. https://doi.org/10.1016/j.jagp.2023.08.010
- Frostad, S., Rozakou-Soumalia, N., Dârvariu, Ş., Foruzesh, B., Azkia, H., Larsen, M. P., Rowshandel, E., & Sjögren, J. M. (2022). BMI at Discharge from Treatment Predicts Relapse in Anorexia Nervosa: A Systematic Scoping Review. Journal of personalized medicine, 12(5), 836. https://doi.org/10.3390/jpm12050836
- Stice, E., Rohde, P., Shaw, H., & Desjardins, C. (2020). Weight suppression increases odds for future onset of anorexia nervosa, bulimia nervosa, and purging disorder, but not binge eating disorder. The American journal of clinical nutrition, 112(4), 941–947. https://doi.org/10.1093/ajcn/nqaa146